NO860775L - Fremgangsm¨te for fremstilling og rensing av lymfokiner. - Google Patents

Fremgangsm¨te for fremstilling og rensing av lymfokiner.

Info

Publication number
NO860775L
NO860775L NO86860775A NO860775A NO860775L NO 860775 L NO860775 L NO 860775L NO 86860775 A NO86860775 A NO 86860775A NO 860775 A NO860775 A NO 860775A NO 860775 L NO860775 L NO 860775L
Authority
NO
Norway
Prior art keywords
csf
cdna
preparing
protein
rna
Prior art date
Application number
NO86860775A
Other languages
English (en)
Other versions
NO179455B (no
NO179455C (no
Inventor
Steven C Clark
Randal J Kaufman
Gordon G Wong
Elizabeth A Wang
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27417446&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO860775(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO860775L publication Critical patent/NO860775L/no
Priority to NO19943300A priority Critical patent/NO314941B1/no
Priority to NO961452A priority patent/NO307348B1/no
Publication of NO179455B publication Critical patent/NO179455B/no
Publication of NO179455C publication Critical patent/NO179455C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Debugging And Monitoring (AREA)
  • Detergent Compositions (AREA)
NO860775A 1984-07-06 1986-03-03 Vektor inneholdende genet for humant GM-CSF-protein, fremgangsmåte for fremstilling av proteinet, vertscelle som kan uttrykke proteinet samt plasmid NO179455C (no)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NO19943300A NO314941B1 (no) 1984-07-06 1994-09-07 Fremgangsmåte for å rense et protein
NO961452A NO307348B1 (no) 1984-07-06 1996-04-12 DNA som koder for et humant GM-CSF-protein

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US62834284A 1984-07-06 1984-07-06
US65274284A 1984-09-19 1984-09-19
US65244784A 1984-09-19 1984-09-19
PCT/EP1985/000326 WO1986000639A1 (en) 1984-07-06 1985-07-04 Lymphokine production and purification

Publications (3)

Publication Number Publication Date
NO860775L true NO860775L (no) 1986-03-13
NO179455B NO179455B (no) 1996-07-01
NO179455C NO179455C (no) 1996-10-09

Family

ID=27417446

Family Applications (4)

Application Number Title Priority Date Filing Date
NO860775A NO179455C (no) 1984-07-06 1986-03-03 Vektor inneholdende genet for humant GM-CSF-protein, fremgangsmåte for fremstilling av proteinet, vertscelle som kan uttrykke proteinet samt plasmid
NO19943300A NO314941B1 (no) 1984-07-06 1994-09-07 Fremgangsmåte for å rense et protein
NO961452A NO307348B1 (no) 1984-07-06 1996-04-12 DNA som koder for et humant GM-CSF-protein
NO1996016C NO1996016I1 (no) 1984-07-06 1996-12-18 Molgramostim(GM-CSF)

Family Applications After (3)

Application Number Title Priority Date Filing Date
NO19943300A NO314941B1 (no) 1984-07-06 1994-09-07 Fremgangsmåte for å rense et protein
NO961452A NO307348B1 (no) 1984-07-06 1996-04-12 DNA som koder for et humant GM-CSF-protein
NO1996016C NO1996016I1 (no) 1984-07-06 1996-12-18 Molgramostim(GM-CSF)

Country Status (28)

Country Link
EP (2) EP0337359B1 (no)
JP (4) JP2540509B2 (no)
KR (1) KR910001809B1 (no)
AT (2) ATE67244T1 (no)
AU (3) AU599572B2 (no)
CA (2) CA1341618C (no)
CY (1) CY1629A (no)
DE (3) DE3584089D1 (no)
DK (2) DK168709B1 (no)
ES (1) ES8701226A1 (no)
FI (1) FI108796B (no)
GR (1) GR851643B (no)
HK (2) HK111594A (no)
HU (1) HU208711B (no)
IE (2) IE60819B1 (no)
IL (2) IL75725A (no)
LU (1) LU88337I2 (no)
MY (1) MY102902A (no)
NL (1) NL930089I2 (no)
NO (4) NO179455C (no)
NZ (2) NZ228031A (no)
PL (1) PL153139B1 (no)
PT (1) PT80776B (no)
SA (1) SA94150015A (no)
SG (1) SG108991G (no)
SK (1) SK505985A3 (no)
UA (1) UA39161C2 (no)
WO (1) WO1986000639A1 (no)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU594014B2 (en) * 1984-03-21 1990-03-01 Research Corporation Technologies, Inc. Recombinant DNA molecules
JPS61227526A (ja) * 1984-07-25 1986-10-09 Chugai Pharmaceut Co Ltd 新規なコロニー刺激因子
AU588819B2 (en) * 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene
ZA856108B (en) * 1984-10-29 1986-10-29 Immunex Corp Cloning of human granulocyte-macrophage colony simulating factor gene
KR920003822B1 (ko) * 1984-11-20 1992-05-15 쉐링 바이오텍 코포레이션 인체 과립구 대식 세포 및 호산성 세포 성장 인자 활성을 나타내는 폴리펩티드
EP0211899B1 (en) * 1985-02-05 1992-09-23 Cetus Oncology Corporation Purification of native colony stimulating factor-1
ATE67517T1 (de) * 1985-09-30 1991-10-15 Chugai Pharmaceutical Co Ltd Menschlicher granulozyten-colony stimulierender faktor.
WO1987002060A1 (en) * 1985-10-03 1987-04-09 Biogen N.V. Human granulocyte-macrophage colony stimulating factor-like polypeptides and processes for producing them in high yields in microbial cells
CA1295567C (en) * 1988-07-25 1992-02-11 Lawrence T. Malek Expression system for the secretion of bioactive human granulocyte, macrophage-colony stimulating factor (gm-csf) and other heterologous proteins from streptomyces
US5298603A (en) * 1985-12-21 1994-03-29 Hoechst Aktiengesellschaft GM-CSF protein, its derivatives, the preparation of proteins of this type, and their use
DE3545568A1 (de) * 1985-12-21 1987-07-16 Hoechst Ag Gm-csf-protein, seine derivate, herstellung solcher proteine und ihre verwendung
IL83003A (en) 1986-07-01 1995-07-31 Genetics Inst Factors that soak bone formation
GR871029B (en) 1986-07-14 1987-11-02 Genetics Inst Novel osteoinductive factors
US5162111A (en) * 1986-07-30 1992-11-10 Grabstein Kenneth H Treatment of bacterial diseases with granulocyte-macrophage colony stimulating factor
WO1988001297A1 (en) * 1986-08-11 1988-02-25 Cetus Corporation Expression of g-csf and muteins thereof
GB8624899D0 (en) * 1986-10-17 1986-11-19 Sandoz Ltd Monoclonal antibodies
JPH0618781B2 (ja) * 1986-10-18 1994-03-16 中外製薬株式会社 感染症治療剤
EP0276846A3 (en) * 1987-01-29 1989-07-26 Zymogenetics, Inc. Colony-stimulating factor derivatives
JP2521094B2 (ja) * 1987-04-28 1996-07-31 アムジェン、インコーポレーテッド ヒト顆粒球マクロファ―ジコロニ―刺激因子をコ―ドする合成ｄｎａ、そのｄｎａを含むプラスミド、およびそのｄｎａで形質転換された大腸菌
WO1988010310A1 (en) * 1987-06-25 1988-12-29 Immunex Corporation Bovine granulocyte-macrophage colony stimulating factor
US5391706A (en) * 1987-07-16 1995-02-21 Schering Plough Corporation Purification of GM-CSF
KR930007430B1 (ko) * 1987-07-16 1993-08-10 쉐링 코포레이션 크로마토그래피 단계에 의한 과립구-대식세포 콜로니-자극 인자의 정제방법
IE63514B1 (en) * 1987-07-17 1995-05-03 Schering Biotech Corp Expression vectors for the production of human granulocyte-macrophage colony stimulation factor in a mammalian cell host
AU626530B2 (en) * 1987-07-17 1992-08-06 Schering Biotech Corporation Human granulocyte-macrophage colony stimulating factor and muteins thereof
WO1989001038A1 (en) * 1987-07-24 1989-02-09 Cetus Corporation PRODUCTION OF BIOLOGICALLY ACTIVE FORMS OF CSF USING A BACULOVIRUS (AcNPV)-INSECT CELL EXPRESSION SYSTEM
WO1989011864A1 (en) * 1988-05-31 1989-12-14 Schering Biotech Corporation Method of treating myeloid leukemias
AU618283B2 (en) * 1988-10-10 1991-12-19 Instituto Nazionale Per Lo Studio E La Cura Dei Tumori The use of GM-CSF in the treatment of a patient requiring high-dose chemo- or radiotherapy for cancer
US5811523A (en) 1988-11-10 1998-09-22 Trinchieri; Giorgio Antibodies to natural killer stimulatory factor
JPH0322973A (ja) * 1989-01-19 1991-01-31 Wan Shen-Yuan ヒトヘパトーム細胞系によるコロニー形成促進因子（ＣＳＦｓ）の構成性産生
JPH04503815A (ja) * 1989-07-14 1992-07-09 シェリング・コーポレーション カルボキシル末端から誘導されたｇｍ―ｃｓｆのアンタゴニスト
EP0628057B1 (en) 1992-02-28 1999-10-20 Board Of Regents The University Of Texas System Use of a therapeutical COMPOSITION FOR THE TREATMENT OF THERMAL INJURY
US6004807A (en) * 1992-03-30 1999-12-21 Schering Corporation In vitro generation of human dendritic cells
US6361976B1 (en) 1992-11-24 2002-03-26 S. Christopher Bauer Co-administration of interleukin-3 mutant polypeptides with CSF'S for multi-lineage hematopoietic cell production
US5772992A (en) * 1992-11-24 1998-06-30 G.D. Searle & Co. Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors
US6413509B1 (en) 1992-11-24 2002-07-02 S. Christopher Bauer Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 mutant polypeptides with other hematopoietic growth factors
US6361977B1 (en) 1992-11-24 2002-03-26 S. Christopher Bauer Methods of using multivariant IL-3 hematopoiesis fusion protein
US6403076B1 (en) 1992-11-24 2002-06-11 S. Christopher Bauer Compositions for increasing hematopoiesis with interleukin-3 mutants
US7091319B1 (en) 1992-11-24 2006-08-15 Bauer S Christopher IL-3 variant hematopoiesis fusion protein
US5738849A (en) * 1992-11-24 1998-04-14 G. D. Searle & Co. Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
US6153183A (en) * 1992-11-24 2000-11-28 G. D. Searle & Company Co-administration of interleukin-3 mutant polypeptides with CSF's or cytokines for multi-lineage hematopoietic cell production
US6057133A (en) * 1992-11-24 2000-05-02 G. D. Searle Multivariant human IL-3 fusion proteins and their recombinant production
DK1378572T3 (da) 1993-05-12 2007-02-05 Genetics Inst Llc BMP-11-sammensætninger
DE69331268T2 (de) * 1993-06-30 2002-06-13 Lucky Ltd Modifizierte-Granulocyte-Makrophage-Kolonie-stimulierender-Faktor-Gen und seine Expression in Hefe
US6027919A (en) 1993-12-07 2000-02-22 Genetics Institute, Inc. BMP-12 and BMP-13 proteins and DNA encoding them
US5599536A (en) * 1993-12-13 1997-02-04 Sandoz Ltd. Method for suppressing the acute phase response in a patient receiving IL-6 therapy
US5578301A (en) * 1993-12-14 1996-11-26 Sandoz Ltd. Method for using GM-CSF to reduce the acute phase response in a patient being administered IL-6 therapy
US6165748A (en) 1997-07-11 2000-12-26 Genetics Institute, Inc. Frazzled nucleotide sequences and expression products
US6676937B1 (en) 1998-03-09 2004-01-13 Caritas St. Elizabeth's Medical Center Of Boston Inc. Compositions and methods for modulating vascularization
DE19905501B4 (de) 1999-02-10 2005-05-19 MediGene AG, Gesellschaft für molekularbiologische Kardiologie und Onkologie Verfahren zur Herstellung eines rekombinanten Adeno-assoziierten Virus, geeignete Mittel hierzu sowie Verwendung zur Herstellung eines Arzneimittels
CA2367575A1 (en) * 1999-02-12 2000-08-17 Washington University Stimulating neutrophil function to treat inflammatory bowel disease
CA2394033A1 (en) * 1999-12-10 2001-06-14 Whitehead Institute For Biomedical Research Ibd-related polymorphisms
US6869762B1 (en) 1999-12-10 2005-03-22 Whitehead Institute For Biomedical Research Crohn's disease-related polymorphisms
US6689599B1 (en) 2000-10-20 2004-02-10 Genetics Institute, Llc Aggrecanase molecules
TW200526779A (en) 2001-02-08 2005-08-16 Wyeth Corp Modified and stabilized GDF propeptides and uses thereof
WO2003012038A2 (en) 2001-07-27 2003-02-13 Wyeth Aggrecanase molecules
JP2005515779A (ja) 2002-01-31 2005-06-02 ワイス アグレカナーゼ分子
KR20040088059A (ko) 2002-02-05 2004-10-15 와이어쓰 절두된 아그레카나제 분자
BR0313083A (pt) 2002-07-29 2007-07-17 Wyeth Corp moléculas de adamts4 modificadas,polinucleotìdeo, vetor, processos para produção, composição farmacêutica, bem como uso das mesmas

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4428632A (en) * 1979-08-10 1984-01-31 Thomas & Betts Corporation Coaxial cable transition connector
JPS6030654B2 (ja) * 1980-12-31 1985-07-17 株式会社林原生物化学研究所 ヒトコロニ−刺激因子の製造方法
US4438032A (en) * 1981-01-30 1984-03-20 The Regents Of The University Of California Unique T-lymphocyte line and products derived therefrom
JPH0751511B2 (ja) * 1982-03-15 1995-06-05 味の素株式会社 インターロイキン２を含有してなる癌治療剤
AU594014B2 (en) * 1984-03-21 1990-03-01 Research Corporation Technologies, Inc. Recombinant DNA molecules
ZA856108B (en) * 1984-10-29 1986-10-29 Immunex Corp Cloning of human granulocyte-macrophage colony simulating factor gene
AU588819B2 (en) * 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene

Also Published As

Publication number Publication date
HU208711B (en) 1993-12-28
EP0188479B1 (en) 1991-09-11
MY102902A (en) 1993-03-31
NO943300L (no) 1986-03-13
NO1996016I1 (no) 1996-12-18
JPH06199897A (ja) 1994-07-19
PT80776A (en) 1985-08-01
JPH07163351A (ja) 1995-06-27
DE3588199T2 (de) 1999-04-08
KR910001809B1 (ko) 1991-03-26
EP0337359A2 (en) 1989-10-18
JPH06319557A (ja) 1994-11-22
WO1986000639A1 (en) 1986-01-30
SA94150015A (ar) 2005-12-03
PL153139B1 (en) 1991-03-29
NZ228031A (en) 1991-12-23
DK102886A (da) 1986-03-06
CA1340852C (en) 1999-12-14
IE930961L (en) 1986-01-06
SK280265B6 (sk) 1999-10-08
AU644359B2 (en) 1993-12-09
FI860308A0 (fi) 1986-01-22
SG108991G (en) 1992-03-20
HUT38675A (en) 1986-06-30
NO179455B (no) 1996-07-01
EP0188479A1 (en) 1986-07-30
IL75725A (en) 1993-02-21
NO943300D0 (no) 1994-09-07
IL94754A0 (en) 1991-04-15
SA94150015B1 (ar) 2004-09-04
JPS61502682A (ja) 1986-11-20
HK1011709A1 (en) 1999-07-16
NO961452L (no) 1996-04-12
JP2540509B2 (ja) 1996-10-02
UA39161C2 (uk) 2001-06-15
NO961452D0 (no) 1996-04-12
DE188479T1 (de) 1987-05-21
DK102886D0 (da) 1986-03-06
NO179455C (no) 1996-10-09
HK111594A (en) 1994-10-21
AU599572B2 (en) 1990-07-26
NO314941B1 (no) 2003-06-16
PL254400A1 (en) 1986-06-17
SK505985A3 (en) 1999-10-08
JP2594744B2 (ja) 1997-03-26
EP0337359A3 (en) 1990-02-07
DE3588199D1 (de) 1998-11-26
FI860308A (fi) 1986-01-22
GR851643B (no) 1985-11-26
IE851695L (en) 1986-01-06
ES544868A0 (es) 1986-11-16
IE60819B1 (en) 1994-08-10
DK59493D0 (da) 1993-05-21
ATE67244T1 (de) 1991-09-15
DK168709B1 (da) 1994-05-24
CY1629A (en) 1992-07-10
KR860700264A (ko) 1986-08-01
NZ212645A (en) 1990-02-26
JP2594743B2 (ja) 1997-03-26
NL930089I1 (nl) 1993-10-01
AU628069B2 (en) 1992-09-10
ATE172494T1 (de) 1998-11-15
DK59493A (da) 1993-05-21
FI108796B (fi) 2002-03-28
PT80776B (pt) 1987-09-30
LU88337I2 (fr) 1994-05-04
AU4545685A (en) 1986-02-10
IL75725A0 (en) 1985-11-29
AU4009089A (en) 1989-12-07
EP0337359B1 (en) 1998-10-21
JP2594768B2 (ja) 1997-03-26
DK172679B1 (da) 1999-05-17
DE3584089D1 (de) 1991-10-17
NL930089I2 (nl) 1994-07-01
ES8701226A1 (es) 1986-11-16
CA1341618C (en) 2011-07-19
NO307348B1 (no) 2000-03-20
AU5497690A (en) 1990-09-13

Similar Documents

Publication Publication Date Title
NO860775L (no) Fremgangsm¨te for fremstilling og rensing av lymfokiner.
ATE77104T1 (de) Menge und verfahren zur herstellung rekombinierter erzeugnisse in grosser ausbeute.
DK600386A (da) Proteinekspression

Legal Events

Date Code Title Description
MK1K Patent expired